Return On Equity of KalVista Pharmaceuticals, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
KalVista Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • KalVista Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -232%, a 147% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2024 was -129%, a 66% decline from 2023.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2023 was -77%, a 80% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2022 was -43%, a 41% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -232% -138% -147% 01 Jul 2025 30 Sep 2025
Q2 2025 -161% -69% -76% 01 Apr 2025 30 Jun 2025
Q1 2025 -118% -30% -34% 01 Jan 2025 31 Mar 2025
Q4 2024 -96% -12% -14% 01 Nov 2024 31 Jan 2025
Q3 2024 -94% -27% -40% 01 Jul 2024 30 Sep 2024
Q2 2024 -92% -31% -51% 01 Apr 2024 30 Jun 2024
Q1 2024 -88% -31% -55% 01 Jan 2024 31 Mar 2024
Q4 2023 -84% -31% -58% 01 Nov 2023 31 Jan 2024
Q3 2023 -67% -15% -28% 01 Aug 2023 31 Oct 2023
Q2 2023 -61% -15% -33% 01 May 2023 31 Jul 2023
Q1 2023 -57% -19% -49% 01 Feb 2023 30 Apr 2023
Q4 2022 -54% -22% -71% 01 Nov 2022 31 Jan 2023
Q3 2022 -52% -22% -70% 01 Aug 2022 31 Oct 2022
Q2 2022 -45% -13% -38% 01 May 2022 31 Jul 2022
Q1 2022 -38% +2.6% +6.3% 01 Feb 2022 30 Apr 2022
Q4 2021 -31% +23% +42% 01 Nov 2021 31 Jan 2022
Q3 2021 -31% +17% +35% 01 Aug 2021 31 Oct 2021
Q2 2021 -33% +4.7% +13% 01 May 2021 31 Jul 2021
Q1 2021 -41% -9.4% -30% 01 Feb 2021 30 Apr 2021
Q4 2020 -54% -22% -67% 01 Nov 2020 31 Jan 2021
Q3 2020 -47% -22% -85% 01 Aug 2020 31 Oct 2020
Q2 2020 -38% -15% -67% 01 May 2020 31 Jul 2020
Q1 2020 -31% -6.3% -25% 01 Feb 2020 30 Apr 2020
Q4 2019 -32% -13% -64% 01 Nov 2019 31 Jan 2020
Q3 2019 -26% +4.4% +15% 01 Aug 2019 31 Oct 2019
Q2 2019 -23% +34% +60% 01 May 2019 31 Jul 2019
Q1 2019 -25% +31% +55% 01 Feb 2019 30 Apr 2019
Q4 2018 -20% +46% +70% 01 Nov 2018 31 Jan 2019
Q3 2018 -30% +40% +57% 01 Aug 2018 31 Oct 2018
Q2 2018 -56% +4.2% +6.9% 01 May 2018 31 Jul 2018
Q1 2018 -56% +7.8% +12% 01 Feb 2018 30 Apr 2018
Q4 2017 -66% -0.88% -1.4% 01 Nov 2017 31 Jan 2018
Q3 2017 -70% -16% -29% 01 Aug 2017 31 Oct 2017
Q2 2017 -60% -6.6% -12% 01 May 2017 31 Jul 2017
Q1 2017 -63% -12% -25% 01 Feb 2017 30 Apr 2017
Q4 2016 -65% +22% +25% 01 Nov 2016 31 Jan 2017
Q3 2016 -54% +406% +88% 01 Jul 2016 30 Sep 2016
Q2 2016 -54% 01 Apr 2016 30 Jun 2016
Q1 2016 -51% 01 Jan 2016 31 Mar 2016
Q4 2015 -87% 01 Oct 2015 31 Dec 2015
Q3 2015 -460% 01 Jul 2015 30 Sep 2015

KalVista Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -129% -51% -66% 01 May 2024 30 Apr 2025
2023 -77% -35% -80% 01 May 2023 30 Apr 2024
2022 -43% +29% +41% 01 May 2022 30 Apr 2023
2021 -72% -23% -46% 01 May 2021 30 Apr 2022
2020 -50% -15% -42% 01 May 2020 30 Apr 2021
2019 -35% +38% +52% 01 May 2019 30 Apr 2020
2018 -73% -27% -58% 01 May 2018 30 Apr 2019
2017 -46% -10% -29% 01 May 2017 30 Apr 2018
2016 -36% +51% +59% 01 May 2016 30 Apr 2017
2015 -87% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.